General Session Topics

Retina Unplugged*

This half-day program will provide data-driven, unfiltered, and “raw” discussions about drugs and devices that may impact retina. Join conversations with industry experts and clinical experts on the most debated topics in all of retina.

  • Next Generation Anti-VEGF
  • Gene Therapy
  • Financing
  • Biosimilars
  • Dry AMD and Geographic Atrophy
  • New Pathways in Retinal Diseases
  • Drug Induced Uveitis
  • Front-line Therapies and Novel Drug Delivery for Uveitis
  • Vitrectomy in Uveitis
  • How to Not Miss Infectious Uveitis
  • Disinfection Prior to Intravitreal Injection: Is Povidone-iodine the Only Option?
  • Suprachoroidal Triamcinolone for Uveitis (Overview of the PEACHTREE and MAGNOLIA Studies)
Macular Surgery
  • Autologous Transplantation of Internal Limiting Membrane vs Retina Expansion Technique vs Amniotic Membrane Plaque for Refractory Macular Holes: Results at 24 Months of Follow-up Autologous Retinal
  • The Influence of Crescent-shaped Selective Internal Limiting Membrane Staining in Brilliant Blue G Assisted Temporal Inverted Flap Technique
  • Surgical Results for Myopic Traction Maculopathy in Asian Patients
  • Autologous Retinal Transplant: New Tips and Tricks
  • Reoperations for Refractory Macular Hole after ILM Flap Technique
  • Customized Management of Myopic Traction Maculopathy based on the MTM Stating System: Long-term Results
  • How to Overcome Surgical Challenges in Myopic Macular Holes with Very Long Axial Lengths
  • Comparing ILM Plug vs. Amniotic Membrane in the Management of Macular Holes: Short- and Long-term Results
Miscellaneous Topics
  • Management of Chronic Central Serous Chorioretinopathy
  • Vitreous Composition Modification after Transpalpebral Electrical Stimulation of the Eye: Biochemical Analysis
  • Intravitreal Methotrexate Injections in the Management of Advance PVR
  • Update on Macular Telangiectasia Type 2
  • COVID-19 and Venous Occlusion
  • Outcomes of Recurrent Myopic CNV Treated with Anti-VEGF Therapy
  • Quantitative Effects of Non-adherence to Intravitreal Anti-VEGF Therapy on Visual Outcomes in nAMD
  • Inherited Retinal Disease Fascinomas
  • Inherited Retinal Disease Management in South America
  • Photodynamic Therapy as a Treatment Option for Peripapillary Pachychoroid Syndrome
Surgical Technology
  • Surgical Implantation of the Port Delivery System: Best Practices
  • Hemorrhagic Complications after Sutureless Vitrectomy
  • Endoscopic Vitreoretinal Surgeries
  • Hypersonic Vitrectomy
  • Optics in Use of Heads-up Surgery
  • Virtual Reality to Replace the Operating Microscope
  • Prospective Randomized Trial Comparing the Post-operative Outcome in 27 Gauge vs Larger Gauge Vitrectomy
  • The Future of Office Based Vitrectomy is Now
Retinal Detachment Surgery
  • Vitrectomy vs. Vitrectomy with Scleral Buckling in the Treatment of Giant Retinal Tear Related Retinal Detachments: An International Multicenter Study
  • Use of Air in Retina Detachment Surgery: 2-year Results
  • Reduce the Surgical Time by Not Completely Draining the Subretinal Fluid in Retinal Detachment Cases
  • Multimodal Imaging in Retinal Detachment Repair
Gene and Cell Therapy
  • Intravitreal Retinal Progenitor Cells for the Treatment of Retinitis Pigmentosa
  • Subretinal Gene Therapy Robotic Precision and Accuracy Trumps Manual Delivery
  • Surgical Delivery of Gene and Cell Therapies
  • Inherited Retinal Disease Gene Therapy Trial Updates
  • Best Practices in Retinal Gene Therapy Surgery
  • Genetic Mechanisms and Clinical Implications
Imaging and Artificial Intelligence
  • Imaging Biomarkers of Retinal Function in Eyes with Treatment-naive Mild Diabetic Retinopathy
  • Retinal Sensitivity Testing and Imaging using 2-Photon Pulsed Laser Technologies
  • Remote Visual Monitoring for Retinal Diseases
  • Novel Imaging Tips for Assessing Polypoidal Lesions
  • AI Algorithm to Predict Progression to GA from Intermediate AMD
  • Augmented Reality in Ophthalmology and Retina: Clinical and Surgical Applications
  • Implementation of AI for ROP in Low- and Middle-income Countries: Opportunities and Challenges
  • Characterization of Epiretinal Membrane in Retinal Vein Occlusion using OCTA
  • Navigated Single-capture 3D and Cross-Sectional Widefield OCT of the Mid and Peripheral Retina and Vitreoretinal Interface
  • Narrow Beam OCTA: A Promising New Technology
  • The Most Advanced Choroidal Imaging
Age-related Macular Degeneration
  • First Results of the Miniature Telescope in Dry AMD
  • Novel Therapeutic Treatment for Anti-VEGF Therapy
  • Updates in PCV Management
  • The Early Detection of Neovascular AMD: Understanding Factors that Affect Outcomes from Treating Early
  • Incident Geographic Atrophy in Wet Age-related Macular Degeneration: A Meta-analysis
  • Choroidal Vascularity Index is Associated with Geographic Atrophy Progression
  • Faricimab Phase 3 nAMD TENAYA and LUCERNE 2-year Study Results
  • Intravitreal Gene Therapy for AMD
  • Port Delivery System for AMD
  • Sub-retinal Gene Therapy for AMD
  • Biosimilars: Takeaways from India
Diabetic Vitrectomy
  • Diabetic Retinopathy: From Pathophysiology to Modern 3D Surgery, Where Are We Now?
  • Paradigm Shifts in the Surgical Management of Diabetic Retinopathy Complications
  • Early PPV for Treatment of Complications of Proliferative Diabetic Retinopathy
  • Essentials of Diabetic Vitrectomy
Medical Retina: Diabetic Macular Edema and Diabetic Retinopathy
  • The Use of a Combination of Ozurdex and Eylea vs. Eylea Monotherapy for DME: A Prospective, Comparative Trial (COED Trial)
  • Does Anti-VEGF Treatment Impact Retinal Non-perfusion in DR?
  • The VITDEC Study: Vitrectomized vs. Non-vitrectomized Patients and DEX Implant Results
  • Palladian Data DME
  • Brolucizumab for the Treatment of DME: 1-year Results from the Kingfisher Study
  • How Evaluate Neurodegeneration in Diabetes in Clinical Practice
  • Yosemite and Rhine Faricinab for DME
  • Port Delivery System for DME and DR
Trauma and Proliferative Vitreoretinopathy Surgery
  • Severe Trauma Reconstruction
  • The Severely Traumatized Eye: Never Give Up
  • Surgical Management of Severe Ocular Perforating Injuries
  • Surgical Techniques and Outcomes of Phaco-vitrectomy without Buckle for Complex Retinal Detachment
  • Large Retinotomies for Inferior PVR in Silicone Oil filled Eyes
  • Tips and Tricks for Transconjunctival Choroidal Detachment Drainage
Controversies: RWC Debates
  • Is There a Role for Brolucizumab in Wet AMD?
  • Is There a Role for Scleral Buckling in RD Surgery?
  • When Should Geographic Atrophy be Treated, Early or Late?
  • Should Wet AMD be Treated on Label?
Pediatrics and Pediatric Surgery
  • The Management of Pediatric Rhegmatogenous Retinal Detachments
  • Long-term (>10 years) of Anti-VEGF in ROP Studies
  • The Mathematics of ROP
  • Management of Pediatric Combined Hamartoma of Retina and Retina Pigment Epithelium: Conservative vs. Surgical Approach
  • Fovea-threatening and Recent Fovea-involving Peripheral Coats Disease: Effects of Posture and Prompt Intervention
  • Treatment Update for Inherited Retinal Degenerations
  • General Considerations for Pediatric Vitrectomy
Ocular Oncology
  • Breaking Findings from the COOG2 Trial
  • Vitrectomy for Removal of Subretinal Masses: Cysts and Tumors
  • Liquid Biopsy in Ocular Oncology: Ready for Prime Time
  • Diagnosis of Small Choroidal Melanoma: Is Machine Learning Any Better

Panel Discussion Topics

  • Uveitis
  • Complex Macular Holes Surgery
  • Secondary IOL
  • Retinal Detachment Surgery
  • Gene Therapy
  • Imaging
  • Biosimilars
  • Diabetic Vitrectomy
  • Diabetic Retinopathy
  • Pediatric Retina
  • Ocular Oncology
  • Medical Mysteries and Diagnostic Challenges